Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Neural Therapeutics Inc. ( (TSE:NURL) ) has shared an update.
Neural Therapeutics Inc. has commenced trading on the Frankfurt Stock Exchange, aiming to access a broader international investor base and enhance liquidity. This move is expected to support the company’s growth strategy, including the proposed acquisition of Hanf.com, by increasing brand awareness and retail sales in Germany, thus strengthening its market position.
More about Neural Therapeutics Inc.
Neural Therapeutics Inc. is a leader in ethnobotanical drug discovery, focusing on developing therapeutic drugs for mental illnesses related to substance use disorders, such as alcohol and opioid dependence. The company employs an innovative approach using sub-hallucinogenic doses of mescaline extract to enhance safety and scalability while maintaining therapeutic efficacy.
Average Trading Volume: 117,987
Find detailed analytics on NURL stock on TipRanks’ Stock Analysis page.